In line with this argument is the fact that in various types of cancer (e.g., breast cancer) COX2 is overexpressed, leading to chronic inflammation supporting cell proliferation, neovascularization, and cancer growth [5,59]. Here, PTGS2 is linked to breast carcinoma.